TrialThe Lancet. Neurology2015

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.

Subha V Raman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.